Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$835M |
| 2 |
VIAB
Viacom Inc. Class B
VIAB
|
+$827M |
| 3 |
eBay
EBAY
|
+$761M |
| 4 |
Apple
AAPL
|
+$657M |
| 5 |
Microchip Technology
MCHP
|
+$542M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$877M |
| 2 |
CSX Corp
CSX
|
+$821M |
| 3 |
Microsoft
MSFT
|
+$796M |
| 4 |
STJ
St Jude Medical
STJ
|
+$743M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$685M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.79% |
| 2 | Financials | 17.39% |
| 3 | Technology | 13.07% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$121B
| $8.3B | 2% |
152,538,269
+4,295,831
| +3% | +$236M |
2013 Q2
15 quarters
|
|
|
2
Microsoft
MSFT
$3.97T
| $8.13B | 1.96% |
123,424,443
-12,425,951
| -9% | -$796M |
2013 Q2
15 quarters
|
|
3
Merck
MRK
$359B
| $7.38B | 1.78% |
121,737,511
-8,415,528
| -6% | -$511M |
2013 Q2
15 quarters
|
|
4
UnitedHealth
UNH
$340B
| $6.18B | 1.49% |
37,680,871
-1,852,660
| -5% | -$303M |
2013 Q2
15 quarters
|
|
|
5
Apple
AAPL
$4.91T
| $5.79B | 1.39% |
161,252,104
+19,966,556
| +14% | +$657M |
2013 Q2
15 quarters
|
|
6
Medtronic
MDT
$113B
| $5.51B | 1.33% |
68,384,486
-6,497,585
| -9% | -$508M |
2013 Q2
15 quarters
|
|
7
JPMorgan Chase
JPM
$885B
| $5.51B | 1.33% |
62,677,811
-2,454,158
| -4% | -$217M |
2013 Q2
15 quarters
|
|
8
Wells Fargo
WFC
$253B
| $5.41B | 1.3% |
97,189,365
-3,351,450
| -3% | -$190M |
2013 Q2
15 quarters
|
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $5.15B | 1.24% |
21,555,942
-1,130,455
| -5% | -$263M |
2013 Q2
15 quarters
|
|
10
Eli Lilly
LLY
$1.05T
| $4.77B | 1.15% |
56,658,958
-148,554
| -0.3% | -$11.9M |
2013 Q2
15 quarters
|
|
11
Bank of America
BAC
$380B
| $4.69B | 1.13% |
198,685,780
-5,625,097
| -3% | -$133M |
2013 Q2
15 quarters
|
|
12
Chubb
CB
$132B
| $4.52B | 1.09% |
33,210,156
-18,492
| -0.1% | -$2.49M |
2013 Q2
15 quarters
|
|
13
Chevron
CVX
$416B
| $4.52B | 1.09% |
42,122,899
+1,687,569
| +4% | +$189M |
2013 Q2
15 quarters
|
|
14
PNC Financial Services
PNC
$87.5B
| $4.47B | 1.08% |
37,153,615
-3,648,556
| -9% | -$447M |
2013 Q2
15 quarters
|
|
15
Johnson & Johnson
JNJ
$630B
| $4.15B | 1% |
33,299,365
-1,499,458
| -4% | -$179M |
2013 Q2
15 quarters
|
|
16
ExxonMobil
XOM
$695B
| $4.09B | 0.98% |
49,819,518
+774,086
| +2% | +$64.7M |
2013 Q2
15 quarters
|
|
17
Intel
INTC
$553B
| $4.02B | 0.97% |
111,452,936
-11,493,169
| -9% | -$416M |
2013 Q2
15 quarters
|
|
18
Cisco
CSCO
$467B
| $3.77B | 0.91% |
111,529,451
+9,958,755
| +10% | +$323M |
2013 Q2
15 quarters
|
|
19
McKesson
MCK
$109B
| $3.37B | 0.81% |
22,730,846
+192,254
| +0.9% | +$28.2M |
2013 Q2
15 quarters
|
|
20
PepsiCo
PEP
$172B
| $3.29B | 0.79% |
29,390,562
+1,922,106
| +7% | +$206M |
2013 Q2
15 quarters
|
|
21
Comcast
CMCSA
$73.3B
| $3.28B | 0.79% |
87,354,659
-4,010,819
| -4% | -$149M |
2013 Q2
15 quarters
|
|
|
MRSH
22
Marsh
MRSH
$83.9B
| $3.22B | 0.77% |
43,526,413
-312,832
| -0.7% | -$22.4M |
2013 Q2
15 quarters
|
|
23
Cardinal Health
CAH
$55B
| $3.22B | 0.77% |
39,425,487
-695,079
| -2% | -$54.7M |
2013 Q2
15 quarters
|
|
24
United Parcel Service
UPS
$80.5B
| $3.15B | 0.76% |
29,387,614
+1,117,802
| +4% | +$122M |
2013 Q2
15 quarters
|
|
25
Philip Morris
PM
$314B
| $3.03B | 0.73% |
26,808,184
+361,617
| +1% | +$37.3M |
2013 Q2
15 quarters
|
|
Similar funds
Wellington Management Group's Q1 2017 Portfolio in Review
As of Q1 2017, Wellington Management Group held 2,408 positions worth $415B, up 4.1% from $399B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wellington Management Group's Q1 2017 filing shows 238 new, 909 increased, 889 reduced and 178 closed positions. Its largest new stake was Financial Engines, Inc.: 5,371,574 shares worth $234M. The largest sale was Mondelez International, an estimated $877M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q1 2017 buy was Financial Engines, Inc.: 5,371,574 shares worth $234M.
- Wellington Management Group added most to Abbott in Q1 2017, an estimated $835M increase.
- Wellington Management Group's biggest Q1 2017 reduction was Mondelez International, cutting an estimated $877M.
- Wellington Management Group fully exited St Jude Medical in Q1 2017, selling an estimated $743M.
- Wellington Management Group's ten largest holdings make up 15% of its $415B portfolio in Q1 2017.
- Wellington Management Group opened 238 new positions and closed 178 in Q1 2017.
- Wellington Management Group's portfolio value rose 4.1% quarter-over-quarter to $415B.
Based on Wellington Management Group's 13F filing for Q1 2017, filed 11 May 2017.